Cargando…
Kurarinone Attenuates BLM-Induced Pulmonary Fibrosis via Inhibiting TGF-β Signaling Pathways
Idiopathic pulmonary fibrosis (IPF) is a refractory interstitial lung disease for which there is no effective treatment. Although the pathogenesis of IPF is not fully understood, TGF-β and epithelial–mesenchymal transition (EMT) have been shown to be involved in the fibrotic changes of lung tissues....
Autores principales: | Park, Soo-Jin, Kim, Tae-hyoun, Lee, Kiram, Kang, Min-Ah, Jang, Hyun-Jae, Ryu, Hyung-Won, Oh, Sei-Ryang, Lee, Hyun-Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395032/ https://www.ncbi.nlm.nih.gov/pubmed/34445094 http://dx.doi.org/10.3390/ijms22168388 |
Ejemplares similares
-
Theophylline Attenuates BLM-Induced Pulmonary Fibrosis by Inhibiting Th17 Differentiation
por: Park, Soo-Jin, et al.
Publicado: (2023) -
Picroside II Isolated from Pseudolysimachion rotundum var. subintegrum Inhibits Glucocorticoid Refractory Serum Amyloid A (SAA) Expression and SAA-induced IL-33 Secretion
por: Lee, Kiram, et al.
Publicado: (2019) -
An In Vitro Study for Evaluating Permeability and Metabolism of Kurarinone
por: Qin, Youfa, et al.
Publicado: (2020) -
In Vitro and In Silico Characterization
of Kurarinone as a Dopamine D(1A) Receptor
Antagonist and D(2L) and D(4) Receptor Agonist
por: Prajapati, Ritu, et al.
Publicado: (2021) -
Del-1, an Endogenous Inhibitor of TGF-β Activation, Attenuates Fibrosis
por: Kim, Dong-Young, et al.
Publicado: (2020)